Rostec flu vaccine approved for children from six months and pregnant women. https://gxpnews.net/en/2021/03/rostec-flu-vaccine-approved-for-children-from-six-months-and-pregnant-women/
The Circle of Good Fund will provide medicines for children with three more orphan diseases. https://gxpnews.net/en/2021/03/the-circle-of-good-fund-will-provide-medicines-for-children-with-three-more-orphan-diseases/
In 2020, the Russian pharmaceutical market showed growth above forecasts: its positive dynamics in ruble terms amounted to 9.8% instead of the expected 5-6%. The volume of the pharmaceutical market of the Russian Federation in 2020 reached 2.040 trillion rubles, the research company DMS Group reports in the review “Pharmaceutical Market of Russia – 2020.”
📰 The State Duma of the Russian Federation adopted in the first reading a bill that allows pharmacy organizations, veterinary pharmacies and individual entrepreneurs with a license for pharmaceutical activities to use drugs in the production of drugs instead of pharmaceutical stations.
The Russian pharmaceutical industry is ready to produce its own anti-HPV, chickenpox and rotavirus vaccine under the Pharma-2030 program, said Mikhail Nekrasov, CEO of NANOLEC pharmaceutical company, at the XVI International Conference “Pharmaceutical Business in Russia – 2021” on March 11.
Biocad for the first time in the Russian pharmaceutical industry published a report on corporate social responsibility (CSR) on the basis of the international GRID Standards (Global Reporting Initiative), the company reports.
The Sputnik V vaccine during clinical trials showed effectiveness against the “British” version of coronavirus, said Russian Health Minister Mikhail Murashko.
On March 17, the State Duma adopted a government bill in first reading, according to which the Cabinet of Ministers is empowered to make a decision on the use of inventions for the production of drugs without a patent, followed by compensation to the patent holder.
Russian President Vladimir Putin was vaccinated against coronavirus, RIA Novosti reported with reference to the official representative of President Dmitry Peskov. «We will not specifically say which one. All three Russian vaccines are absolutely reliable, they are very good and effective,» he says.
The Russian Direct Investment Fund (RDIF) and the Indian company Stelis Biopharma have agreed to partner to produce 200 million doses of the Sputnik V vaccine, the fund said.
On April 12, 2021, the Russian state GMP inspectorate, created on the basis of the State Institute of Drugs and Good Practices (SID&GP) of the Ministry of Industry and Trade of Russia, celebrates its 5th anniversary. The first inspection of foreign pharmaceutical companies for compliance with GMP standards took place in 2016 on Cosmonautics Day.
The Russian company R-Pharm, which produces the Sputnik V vaccine, plans to start drug production in Germany in the summer of 2021, TASS reports citing the DPA agency. According to the German agency, production can be deployed in June or July at a plant in the Bavarian city of Illertissen.
The Federal Antimonopoly Service has agreed to reduce the limit price for the EpiVakKorona vaccine from 9542 rubles. up to 4210 rubles. for a pack of 10 ampoules, according to the base of decisions of the antimonopoly department.
The Ministry of Health of Russia issued permission to conduct phase I and II clinical trials of the Epivakkorona-N coronavirus vaccine of center Vector. This is evidenced by the data of the state register of permits for research of the ministry.
The production of the Pentaxim five-component vaccine (the development of the French Sanofi) is planned to be localized in Russia next year, said Maxim Stetsyuk, executive director of the Nanolek manufacturing company.
The Federation Council at a plenary meeting on April 23 approved a bill on the use by the government of inventions and useful models in the field of health care, as well as the release of medicines without the permission of the patent holder in the interests of national security in emergency cases.